DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.

Translational psychiatry

Volumn 3, Issue , 2013, Pages

  Powell, T R ^a   Smith, R G ^b   Hackinger, S ^b   Schalkwyk, L C ^b   Uher, R ^b   McGuffin, P ^b   Mill, J ^b   Tansey, K E ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; IL11 PROTEIN, HUMAN; INTERLEUKIN 11; NORTRIPTYLINE;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENETIC EPIGENESIS; GENETICS; HUMAN; MAJOR DEPRESSION; MALE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; CPG ISLANDS; DEPRESSIVE DISORDER, MAJOR; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HUMANS; INTERLEUKIN-11; MALE; MIDDLE AGED; NORTRIPTYLINE; REGRESSION ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84893517465     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2013.73     Document Type: Article

References (0)